Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign… Click […]
After securing a place in a European program designed to accelerate the process of getting medicines to patients, BioCryst Pharmaceuticals has landed a spot in a similar U.S. program. Click here to view original post
Years ago, you stumbled out of college, grabbed a job and snagged a two-bedroom apartment with a roommate as you powered into your career. But that dynamic is changing, as a new apartment building in […]
A Durham-based pharmaceutical company plans to raise $15 million as it prepares to seek regulatory approval for its treatment for a viral skin infection. Click here to view original post
As Samsung Biologics, the biotech division of the Samsung Group, places more emphasis on manufacturing, the company is inking a major new contract with Novartis. The deal is worth $81 million, according to a regulatory […]
RTI International has landed a seven-year contract with the federal government, a major source of funding for the organization. Click here to view original post
The idea for MagnaReady has its roots in a Wolfpack locker room at North Carolina State University. Click here to view original post
ASHEVILLE, N.C., June 8, 2022 /PRNewswire/ — CooperRiis Healing Community is pleased to announce Ride Above Mental Illness, a peer-to-peer fundraising event. Inspired by Western North Carolina resident Jeremiah Reiner, CooperRiis will be raising awareness […]
A publicly-traded real estate investment trust has acquired three medical office buildings in Cary. Click here to view original post
Novant Health is underway on a new five-story bed tower at Matthews Medical Center. Click here to view original post
Copyright © 2023 Biotech Networks
